These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 20502360

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer.
    Muallaoglu S, Karadeniz C, Mertsoylu H, Ayberk Besen A, Sezer A, Murat Sedef A, Kose F, Ozyilkan O.
    J BUON; 2014; 19(2):453-8. PubMed ID: 24965406
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
    Hsu LH, Chu NM, Liu CC, Tsai SY, You DL, Ko JS, Lu MC, Feng AC.
    Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
    [Abstract] [Full Text] [Related]

  • 7. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases.
    Kawaguchi T, Matsumura A, Fukai S, Tamura A, Saito R, Zell JA, Maruyama Y, Ziogas A, Kawahara M, Ignatius Ou SH.
    J Thorac Oncol; 2010 Jul; 5(7):1001-10. PubMed ID: 20526205
    [Abstract] [Full Text] [Related]

  • 8. Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.
    Kogure Y, Ando M, Saka H, Chiba Y, Yamamoto N, Asami K, Hirashima T, Seto T, Nagase S, Otsuka K, Yanagihara K, Takeda K, Okamoto I, Aoki T, Takayama K, Yamasaki M, Kudoh S, Katakami N, Miyazaki M, Nakagawa K.
    J Thorac Oncol; 2013 Jun; 8(6):753-8. PubMed ID: 23575412
    [Abstract] [Full Text] [Related]

  • 9. Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors.
    Chen KY, Chen JH, Shih JY, Yang CH, Yu CJ, Yang PC.
    J Thorac Oncol; 2010 Jan; 5(1):82-9. PubMed ID: 19884854
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A, Fohlin H, Sörenson S.
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [Abstract] [Full Text] [Related]

  • 11. Primary signet-ring carcinoma (SRC) of the lung: a population-based epidemiologic study of 262 cases with comparison to adenocarcinoma of the lung.
    Ou SH, Ziogas A, Zell JA.
    J Thorac Oncol; 2010 Apr; 5(4):420-7. PubMed ID: 20130484
    [Abstract] [Full Text] [Related]

  • 12. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K, Podhipak A, Narksawat K, Supaattagorn P, Tipayamongkholgul M.
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [Abstract] [Full Text] [Related]

  • 13. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies.
    Ou SH, Zell JA.
    J Thorac Oncol; 2009 Oct; 4(10):1202-11. PubMed ID: 19701111
    [Abstract] [Full Text] [Related]

  • 14. Smoking status at diagnosis and histology type as determinants of long-term outcomes of lung cancer patients.
    Poullis M, McShane J, Shaw M, Shackcloth M, Page R, Mediratta N, Gosney J.
    Eur J Cardiothorac Surg; 2013 May; 43(5):919-24. PubMed ID: 22898398
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
    Ou SH, Ziogas A, Zell JA.
    J Thorac Oncol; 2009 Jan; 4(1):37-43. PubMed ID: 19096304
    [Abstract] [Full Text] [Related]

  • 16. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
    Subramanian J, Velcheti V, Gao F, Govindan R.
    J Thorac Oncol; 2007 Sep; 2(9):827-30. PubMed ID: 17805060
    [Abstract] [Full Text] [Related]

  • 17. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials.
    Hasegawa Y, Ando M, Maemondo M, Yamamoto S, Isa S, Saka H, Kubo A, Kawaguchi T, Takada M, Rosell R, Kurata T, Ou SH.
    Oncologist; 2015 Mar; 20(3):307-15. PubMed ID: 25657199
    [Abstract] [Full Text] [Related]

  • 18. First-line gefitinib treatment for patients with advanced non-small cell lung cancer with poor performance status.
    Lee YJ, Kim HT, Han JY, Yun T, Lee GK, Kim HY, Sung JH, Lee JS.
    J Thorac Oncol; 2010 Mar; 5(3):361-8. PubMed ID: 20107420
    [Abstract] [Full Text] [Related]

  • 19. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.
    Visbal AL, Williams BA, Nichols FC, Marks RS, Jett JR, Aubry MC, Edell ES, Wampfler JA, Molina JR, Yang P.
    Ann Thorac Surg; 2004 Jul; 78(1):209-15; discussion 215. PubMed ID: 15223430
    [Abstract] [Full Text] [Related]

  • 20. Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.
    Ferketich AK, Niland JC, Mamet R, Zornosa C, D'Amico TA, Ettinger DS, Kalemkerian GP, Pisters KM, Reid ME, Otterson GA.
    Cancer; 2013 Feb 15; 119(4):847-53. PubMed ID: 23023590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.